These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 33917394)

  • 1. Penile Cancer-Derived Cells Molecularly Characterized as Models to Guide Targeted Therapies.
    Kuasne H; Canto LMD; Aagaard MM; Muñoz JJM; Jamblinne C; Marchi FA; Scapulatempo-Neto C; Faria EF; Lopes A; Carréno S; Rogatto SR
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact.
    Kuasne H; Barros-Filho MC; Busso-Lopes A; Marchi FA; Pinheiro M; Muñoz JJ; Scapulatempo-Neto C; Faria EF; Guimarães GC; Lopes A; Trindade-Filho JC; Domingues MA; Drigo SA; Rogatto SR
    Oncotarget; 2017 Feb; 8(9):15294-15306. PubMed ID: 28122331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling reveals the pivotal role of hrHPV driving copy number and gene expression alterations, including mRNA downregulation of TP53 and RB1 in penile cancer.
    Macedo J; Silva E; Nogueira L; Coelho R; da Silva J; Dos Santos A; Teixeira-Júnior AA; Belfort M; Silva G; Khayat A; de Oliveira E; Dos Santos AP; Cavalli LR; Pereira SR
    Mol Carcinog; 2020 Jun; 59(6):604-617. PubMed ID: 32212199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA Sequencing.
    Zhang L; Wei P; Shen X; Zhang Y; Xu B; Zhou J; Fan S; Hao Z; Shi H; Zhang X; Kong R; Xu L; Gao J; Zou D; Liang C
    PLoS One; 2015; 10(7):e0131336. PubMed ID: 26158897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-associated penile cancer: Impact of copy number alterations in miRNA/mRNA interactions and potential druggable targets.
    Silva JD; Nogueira L; Coelho R; Deus A; Khayat A; Marchi R; Oliveira E; Santos APD; Cavalli L; Pereira S
    Cancer Biomark; 2021; 32(2):147-160. PubMed ID: 34151841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma.
    Marchi FA; Martins DC; Barros-Filho MC; Kuasne H; Busso Lopes AF; Brentani H; Trindade Filho JCS; Guimarães GC; Faria EF; Scapulatempo-Neto C; Lopes A; Rogatto SR
    Sci Rep; 2017 Jul; 7(1):6707. PubMed ID: 28751665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets.
    Chipollini J; Chaing S; Azizi M; Kidd LC; Kim P; Spiess PE
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28813024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis.
    Chen J; Yao K; Li Z; Deng C; Wang L; Yu X; Liang P; Xie Q; Chen P; Qin Z; Ye Y; Liu Z; Zhou F; Zhang Z; Han H
    Oncotarget; 2016 Aug; 7(32):51687-51698. PubMed ID: 27351128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targets of Wnt/ß-catenin transcription in penile carcinoma.
    Arya M; Thrasivoulou C; Henrique R; Millar M; Hamblin R; Davda R; Aare K; Masters JR; Thomson C; Muneer A; Patel HR; Ahmed A
    PLoS One; 2015; 10(4):e0124395. PubMed ID: 25901368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
    Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
    Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive characterization of cell cultures and xenografts derived from a human verrucous penile carcinoma.
    Muñoz JJ; Drigo SA; Kuasne H; Villacis RA; Marchi FA; Domingues MA; Lopes A; Santos TG; Rogatto SR
    Tumour Biol; 2016 Aug; 37(8):11375-84. PubMed ID: 26960831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus genotypes and P16INK4A expression in squamous penile carcinoma in Mexican patients.
    Martínez-Bailón C; Mantilla-Morales A; Méndez-Matías G; Alvarado-Cabrero I; Maldonado-Rodríguez R; Quintero-Becerra J; Arias-Flores R; Piña-Sánchez P
    BMC Infect Dis; 2019 Dec; 19(1):1068. PubMed ID: 31856740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic and imunohistochemical characterization of tumoral inflammatory cell infiltrate in invasive penile squamous cell carcinomas: Fox-P3 expression is an independent predictor of recurrence.
    Vassallo J; Rodrigues AF; Campos AH; Rocha RM; da Cunha IW; Zequi SC; Guimarães GC; da Fonseca FP; Lopes A; Cubilla A; Soares FA
    Tumour Biol; 2015 Apr; 36(4):2509-16. PubMed ID: 25557886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic mechanisms in penile carcinoma.
    Kuasne H; Marchi FA; Rogatto SR; de Syllos Cólus IM
    Int J Mol Sci; 2013 May; 14(6):10791-808. PubMed ID: 23702847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to the EAU Guideline Recommendations for Local Tumor Treatment in Penile Cancer: Results of the European PROspective Penile Cancer Study Group Survey (E-PROPS).
    Pallauf M; Hempel MC; Hupe MC; May M; Haccius M; Weckermann D; Lebentrau S; Hoschke B; Necknig U; Pfitzenmaier J; Manka L; Nuhn P; Törzsök P; Lusuardi L; Merseburger AS
    Adv Ther; 2020 Dec; 37(12):4969-4980. PubMed ID: 33038006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines.
    Zhou QH; Deng CZ; Li ZS; Chen JP; Yao K; Huang KB; Liu TY; Liu ZW; Qin ZK; Zhou FJ; Huang W; Han H; Liu RY
    Cell Death Dis; 2018 Jun; 9(6):684. PubMed ID: 29880898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.
    Johnson J; Ascierto ML; Mittal S; Newsome D; Kang L; Briggs M; Tanner K; Marincola FM; Berens ME; Vande Woude GF; Xie Q
    J Transl Med; 2015 Sep; 13():306. PubMed ID: 26381735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear loss and cytoplasmic expression of androgen receptor in penile carcinomas: role as a driver event and as a prognosis factor.
    Kuasne H; Barros-Filho MC; Marchi FA; Drigo SA; Scapulatempo-Neto C; Faria EF; Rogatto SR
    Virchows Arch; 2018 Nov; 473(5):607-614. PubMed ID: 30099587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between human papillomavirus and penile cancer over the past decade: a systematic review and meta-analysis.
    Yu YB; Wang YH; Yang XC; Zhao Y; Wang ML; Liang Y; Niu HT
    Asian J Androl; 2019; 21(4):375-380. PubMed ID: 31134917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
    Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
    BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.